Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction.
De Lorenzo
F
F
Xiao
H
H
Kakkar
V V
VV
D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood* / Q000188:drug therapy* / Q000503:physiopathology; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D011379:Prognosis; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000097:blood
D005343:Fibrinolytic Agents; D017395:Plasminogen Activator Inhibitor 1; D013300:Streptokinase; D010959:Tissue Plasminogen Activator